Bottom line
BHCFX vs JEHSX: the short answer
BHCFX (Baron Health Care Fund) and JEHSX (Health Sciences Trust) are both mutual funds.
But JEHSX is far broader, holding 173 positions to 43 for BHCFX, so beyond the top names it adds exposure BHCFX doesn't have.
JEHSX is cheaper at 1.04% vs 1.1% — a difference of $6.00 a year per $10,000 invested.
Over five years, JEHSX returned +4.2% a year vs +2.5% for BHCFX.
Updated Nov 19, 2026
BHCFX vs JEHSX side by side
| BHCFX | JEHSX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Baron Select | John Hancock |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.1% | 1.04% |
| Annual cost per $10k | $110 | $104 |
| 10-yr cost on $10k (prospectus) | $1,340 | $1,282 |
| Max front load | — | — |
| 12b-1 fee | 0.25% | 0.05% |
| 1-yr return | +10.0% | +19.5% |
| 5-yr return (annualized) | +2.5% | +4.2% |
| 10-yr return (annualized) | — | +8.7% |
| Best quarter | +24.6% | +23.6% |
| Worst quarter | −10.0% | −16.1% |
| Net assets (fund) | $114.1M | $251.3M |
| Number of holdings | 43 | 173 |
| Portfolio turnover | 74% | 68% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | BHCFX | JEHSX | Difference |
|---|---|---|---|
| 2025 | +10.0% | +19.5% | −9.5% |
| 2024 | +1.3% | +1.8% | −0.5% |
| 2023 | +6.2% | +4.3% | +1.9% |
| 2022 | −17.1% | −13.1% | −4.0% |
| 2021 | +15.5% | +11.2% | +4.3% |
| 2020 | +47.4% | +27.2% | +20.2% |
| 2019 | +35.2% | +28.7% | +6.6% |
Source: Fund prospectus bar charts
Holdings overlap
13 of BHCFX's top 25 holdings also appear in JEHSX's top 25.
| Holding | BHCFX | JEHSX |
|---|---|---|
| Eli Lilly & Co | 13.66% | 14.30% |
| Johnson & Johnson | 5.56% | 6.33% |
| Thermo Fisher Scientific Inc | 3.91% | 2.67% |
| UnitedHealth Group Inc | 3.28% | 5.95% |
| Vertex Pharmaceuticals Inc | 2.61% | 2.38% |
| Merck & Co Inc | 2.48% | 4.21% |
| Guardant Health Inc | 2.17% | 1.28% |
| Kymera Therapeutics Inc | 2.01% | 0.93% |
| Gilead Sciences Inc | 1.99% | 2.95% |
| Natera Inc | 1.93% | 1.49% |
| Intuitive Surgical Inc | 1.74% | 1.98% |
| Protagonist Therapeutics Inc | 1.72% | 0.90% |
| Elevance Health Inc | 1.69% | 1.63% |
Source: SEC Form N-PORT
BHCFX top 10
- Eli Lilly & Co — 13.66%
- Mettler-Toledo International Inc — 5.60%
- Johnson & Johnson — 5.56%
- Argenx SE — 4.23%
- Thermo Fisher Scientific Inc — 3.91%
- Roivant Sciences Ltd — 3.88%
- Teva Pharmaceutical Industries Ltd — 3.86%
- Welltower Inc — 3.38%
- UnitedHealth Group Inc — 3.28%
- RadNet Inc — 3.24%
JEHSX top 10
- Eli Lilly and Company — 14.30%
- Johnson and Johnson — 6.33%
- UnitedHealth Group Incorporated — 5.95%
- AbbVie Inc. — 5.28%
- Merck and Co. Inc. — 4.21%
- Gilead Sciences Inc. — 2.95%
- Thermo Fisher Scientific Inc. — 2.67%
- Vertex Pharmaceuticals Incorporated — 2.38%
- Bristol-Myers Squibb Company — 2.22%
- Abbott Laboratories — 2.00%
FAQ
What is the difference between BHCFX and JEHSX?
Which is cheaper, BHCFX or JEHSX?
Should I own both BHCFX and JEHSX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.